04/24/2025
11:15 PM | Kairos Pharma (Filer)
| Form EFFECT | |
04/24/2025
7:30 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
6:09 PM | Kairos Pharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/15/2025
4:30 PM | Kairos Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/07/2025
7:30 AM | Bhowmick Neil (Reporting)
Kairos Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
6:30 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
6:05 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2025
5:51 PM | Kairos Pharma (Issuer)
Yu John S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:52 PM | Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
3:45 PM | Kairos Pharma (Filer)
| Form DEF 14C | |
02/06/2025
8:00 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for KAPA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. |
02/04/2025
11:15 PM | Kairos Pharma (Filer)
| Form EFFECT | |
02/05/2025
5:15 AM | Kairos Pharma (Filer)
| Form 424B3 | |
01/29/2025
6:22 AM | Kairos Pharma (Filer)
| Form PRE 14C | |
01/29/2025
5:39 AM | Kairos Pharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/17/2025
4:20 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
8:41 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2024
7:30 PM | Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
5:03 AM | Kairos Pharma (Issuer)
Samuelson Doug (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
8:53 PM | Kairos Pharma (Issuer)
Yu John S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
7:48 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
1:19 PM | Kairos Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
4:30 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:29 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:10 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:17 PM | Kairos Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/24/2024
8:00 PM | Bae Hyun W. (Reporting)
Kairos Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Yu John S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Samuelson Doug (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Keyoung Hansoo Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
MAZANET ROSEMARY (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Bhowmick Neil (Reporting)
Kairos Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
3:22 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
3:15 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
5:36 AM | Kairos Pharma (Filer)
| Form 424B4 | |
09/16/2024
11:15 PM | Kairos Pharma (Filer)
| Form EFFECT | |
09/12/2024
12:57 PM | Kairos Pharma (Filer)
| Form CERT | |
09/12/2024
11:44 AM | Kairos Pharma (Filer)
| Form 8-A12B | |
08/16/2024
4:30 PM | Kairos Pharma (Filer)
| Form S-1/A | |
06/03/2024
8:13 PM | Kairos Pharma (Filer)
| Form S-1/A | |
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad) Elon Musk has done it again.
He’s developed a powerful new AI model that’s already turning heads — and turning the industry upside down.
Some say it could threaten Google’s search engine dominance. Others believe it could mark the beginning of the end for ChatGPT. This could be your shot to invest alongside Elon Musk — before the public ever gets the chance. |
05/20/2024
7:07 AM | Kairos Pharma (Filer)
| Form S-1/A | |
05/10/2024
7:14 PM | Kairos Pharma (Filer)
| Form S-1/A | |
04/30/2024
7:43 PM | Kairos Pharma (Filer)
| Form S-1/A | |
